(Q33688763)

28 July 2017

1 reference

title

The adverse effects of hormone replacement therapy (English)

1 reference

28 July 2017

2

1 reference

28 July 2017

Tavani A

1

1 reference

28 July 2017

1 May 1999

1 reference

28 July 2017

1 reference

28 July 2017

14

1 reference

28 July 2017

5

1 reference

28 July 2017

347-357

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199914050-00003

28 July 2017

0 references

cites work

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

1 reference

12 December 2020

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

12 December 2020

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1 reference

12 December 2020

Estrogen use, hypertension and stroke in postmenopausal women

1 reference

12 December 2020

Noncontraceptive estrogen use and the occurrence of ovarian cancer

1 reference

12 December 2020

Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group

1 reference

12 December 2020

Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium

1 reference

12 December 2020

The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women

1 reference

12 December 2020

Estrogens, progesterone, and endometrial cancer

1 reference

12 December 2020

Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.

1 reference

12 December 2020

Noncontraceptive estrogen use and epithelial ovarian cancer

1 reference

12 December 2020

Combined oestrogen-progestogen replacement and breast cancer risk

1 reference

12 December 2020

Benefits and risks of estrogen replacement therapy

1 reference

12 December 2020

Postmenopausal female hormone use and venous thromboembolic disease in black women

1 reference

12 December 2020

Estrogen replacement therapy and the risk of venous thrombosis

1 reference

12 December 2020

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

12 December 2020

Case-control study of venous thromboembolism risk in users of hormone replacement therapy

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

The epidemiology of ovarian cancer in Greece: a case-control study

1 reference

12 December 2020

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

12 December 2020

The antiestrogenic effect of cigarette smoking in women

1 reference

12 December 2020

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

12 December 2020

Cancer mortality in Europe: effects of age, cohort of birth and period of death.

1 reference

12 December 2020

Estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

12 December 2020

Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort

1 reference

12 December 2020

Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease

1 reference

12 December 2020

Postmenopausal oestrogen treatment and stroke: a prospective study

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

12 December 2020

Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors

1 reference

12 December 2020

Hormone replacement therapy and endometrial cancer: are current regimens safe?

1 reference

12 December 2020

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

12 December 2020

The epidemiology of endometrial cancer

1 reference

12 December 2020

Risk of venous thrombosis with hormone replacement therapy

1 reference

12 December 2020

Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer

1 reference

12 December 2020

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

12 December 2020

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

12 December 2020

Exogenous progestins and breast cancer

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

12 December 2020

The role of estrogens as a risk factor for stroke in postmenopausal women

1 reference

12 December 2020

Oestrogens and obesity as risk factors for endometrial cancer in Italy

1 reference

12 December 2020

1 reference

12 December 2020

Estrogen replacement therapy and fatal ovarian cancer

1 reference

12 December 2020

Hormone replacement therapy and risk of non-fatal stroke

1 reference

12 December 2020

Estrogen replacement therapy and breast cancer risk

1 reference

12 December 2020

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis

1 reference

12 December 2020

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

1 reference

12 December 2020

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

12 December 2020

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

12 December 2020

Risk of cancer in women receiving hormone replacement therapy

1 reference

12 December 2020

Hormone replacement treatment and breast cancer risk: a cooperative Italian study.

1 reference

12 December 2020

Hormone replacement and breast cancer. A remaining controversy?

1 reference

12 December 2020

Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women

1 reference

12 December 2020

Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group

1 reference

12 December 2020

Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study.

1 reference

12 December 2020

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

12 December 2020

Risk factors for epithelial ovarian cancer in Italy

1 reference

12 December 2020

The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer

1 reference

12 December 2020

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

12 December 2020

The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables

1 reference

12 December 2020

Endometrial cancer risk after discontinuing use of unopposed conjugated estrogens (California, United States).

1 reference

12 December 2020

Determinants of estrogen replacement therapy use in northern Italy

1 reference

12 December 2020

Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study

1 reference

12 December 2020

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

12 December 2020

Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates

1 reference

12 December 2020

Estrogen-progestin replacement therapy and endometrial cancer

1 reference

12 December 2020

Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis

1 reference

12 December 2020

Cause-specific mortality in women receiving hormone replacement therapy

1 reference

12 December 2020

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe

1 reference

12 December 2020

Hormone replacement therapy and risk of colon and rectal cancer.

1 reference

12 December 2020

Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

1 reference

12 December 2020

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

12 December 2020

Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study

1 reference

12 December 2020

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

12 December 2020

Estrogen replacement therapy and ovarian cancer risk

1 reference

12 December 2020

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

12 December 2020

Hormone replacement treatment and breast cancer risk: an age-specific analysis

1 reference

12 December 2020

Stroke in users of low-dose oral contraceptives

1 reference

12 December 2020

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

12 December 2020

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones

1 reference

12 December 2020

Effects of long-term estrogen replacement therapy. I. Metabolic effects

1 reference

12 December 2020

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

1 reference

12 December 2020

Postmenopausal hormone-replacement therapy--time for a reappraisal?

1 reference

12 December 2020

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

12 December 2020

Risks and benefits of long-term treatment with estrogens

1 reference

12 December 2020

Postmenopausal hormone therapy and mortality.

1 reference

12 December 2020

Sex hormones and cardiovascular risk

1 reference

12 December 2020

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

12 December 2020

Risk factors for ovarian cancer: a case-control study

1 reference

12 December 2020

The cancer question: an overview of recent epidemiologic and retrospective data

1 reference

12 December 2020

Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

1 reference

12 December 2020

Population attributable risk for endometrial cancer in northern Italy

1 reference

12 December 2020

Coagulation activation following estrogen administration to postmenopausal women

1 reference

12 December 2020

10.2165/00002512-199914050-00003

Identifiers

DOI

1 reference

PubMed ID

10408735

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10408735